
CVALF
Healthcare · Medical Instruments & Supplies · $81.2M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 20, 2026 | Before the open | 0.02 | 0.10 | +405.0% |
| May 21, 2026 | Before the open | 0.02 | 0.04 | +100.0% |
| Feb 25, 2026 | Before the open | 0.04 | 0.01 | -75.0% |
| Aug 21, 2025 | Before the open | 0.04 | 0.00 | -100.0% |
| May 28, 2025 | Before the open | 0.01 | 0.02 | +100.0% |
| Feb 21, 2025 | Before the open | -0.03 | 0.04 | +233.3% |
| Aug 30, 2021 | Before the open | -0.02 | 0.03 | +255.5% |
| May 31, 2021 | Before the open | 0.00 | 0.03 | — |
| Mar 1, 2021 | Before the open | 0.00 | 0.01 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | -0.01 | — |
| Jul 14, 2020 | After the close | 0.00 | -0.07 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | 0.01 | — |
| Mar 2, 2020 | After the close | 0.00 | -0.11 | — |
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and…
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.04 | — |
| Aug 27, 2019 | After the close | -0.02 | -0.16 | -700.0% |
| May 28, 2019 | After the close | -0.04 | -0.01 | +75.0% |